Filing Details
Prime Medicine, Inc. (NASDAQ:PRME) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PRME
Prime Medicine, Inc. (PRME) Files Quarterly Report for Q0
Filing Details Prime Medicine, Inc. (NASDAQ:PRME) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026. The Healthcare company…
Market Context
Prime Medicine, Inc.'s stock currently trades at $2.95 with a market capitalization of $754.0M.
The 10-Q provides Prime Medicine, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Prime Medicine, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PRME Stock Page
Frequently Asked Questions
Where can I read PRME's SEC filings?
Browse all filings on our PRME SEC filings page.
What types of SEC filings does Prime Medicine, Inc. file?
Public companies like Prime Medicine, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.